Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lozano-Ondoua AN"'
Autor:
Hanlon KE, Lozano-Ondoua AN, Umaretiya PJ, Symons-Liguori AM, Chandramouli A, Moy JK, Kwass WK, Mantyh PW, Nelson MA, Vanderah TW
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2016, Iss Issue 1, Pp 59-71 (2016)
Katherine E Hanlon,1,2 Alysia N Lozano-Ondoua,1 Puja J Umaretiya,1 Ashley M Symons-Liguori,1 Anupama Chandramouli,1 Jamie K Moy,1 William K Kwass,1 Patrick W Mantyh,1 Mark A Nelson,3 Todd W Vanderah,11Department of Pharmacology, University of Arizona
Externí odkaz:
https://doaj.org/article/fdc15611f19a4bba8d6361c18e48854b
Autor:
Vanderah, Todd, Hanlon, Katherine, Lozano-Ondoua, Alysia, Umaretiya, Puja, Symons-Ligouri, Ashley, Chandramouli, Anupama, Moy, Jamie, Kwass, William, Mantyh, Patrick, Nelson, Mark
Introduction: Cannabinoid compounds, both nonspecific as well as agonists selective for either cannabinoid receptor 1 (CB1) or cannabinoid receptor 2 (CB2), have been shown to modulate the tumor microenvironment by inducing apoptosis in tumor cells i
Externí odkaz:
http://hdl.handle.net/10150/614744
http://arizona.openrepository.com/arizona/handle/10150/614744
http://arizona.openrepository.com/arizona/handle/10150/614744
Autor:
Lozano-Ondoua, Alysia N., Wright, Courtney, Vardanyan, Anna, King, Tamara, Largent-Milnes, Tally M., Nelson, Mark, Jimenez-Andrade, Juan Miguel, Mantyh, Patrick W., Vanderah, Todd W.
Publikováno v:
In Life Sciences 2010 86(17):646-653
Publikováno v:
Neuroscience Letters. 557:52-59
Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, but often go undetected and are non-painful. Many types of cancers have a propensity to metastasize to the bone microenvironment first. Tumor burden wit
Publikováno v:
Analgesics for Cancer Pain. :94-101
Autor:
Tally M. Largent-Milnes, DJ Stapleton, Patrick W. Mantyh, Alysia N. Lozano-Ondoua, Anupama Chandramouli, Tw. Vanderah, Puja J. Umaretiya, Katherine E. Hanlon, Mark A. Nelson
Publikováno v:
Cancer Research. 70:P1-11
Cannabinoids have been well established as mediators of tumor cell proliferation in several cancer models. The activity of cannabinoid receptor 1 (CB1) agonists as well as cannabinoid receptor 2 (CB2) agonists have been extensively studied over the l
Cancerous cells can originate in a number of different tissues such as prostate, breast and lung, yet often go undetected and are non-painful. Many types of cancers will metastasize toward the bone microenvironment first. Tumor burden within the bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::754ffb88801aeb7746133282cd3d12a9
https://europepmc.org/articles/PMC4542064/
https://europepmc.org/articles/PMC4542064/
Autor:
Katherine E. Hanlon, Todd W. Vanderah, Alysia N. Lozano-Ondoua, Anupama Chandramouli, Jamie K. Moy, William K Kwass, Puja J. Umaretiya, Patrick W. Mantyh, Ashley M. Symons-Liguori, Mark A. Nelson
Publikováno v:
Breast Cancer : Targets and Therapy
Katherine E Hanlon,1,2 Alysia N Lozano-Ondoua,1 Puja J Umaretiya,1 Ashley M Symons-Liguori,1 Anupama Chandramouli,1 Jamie K Moy,1 William K Kwass,1 Patrick W Mantyh,1 Mark A Nelson,3 Todd W Vanderah,11Department of Pharmacology, University of Arizona
Autor:
Alysia N. Lozano-Ondoua, Henry L Ferland, Patrick W. Mantyh, Mabel Owusu‐Ankomah, Tamara King, Katherine E. Hanlon, Mark A. Nelson, Todd W. Vanderah, Anupama Chandramouli, Ashley M. Symons-Liguori, Frank Porreca, Aaron P. Bloom, Juan Miguel Jimenez-Andrade, Tijana Nikolich‐Zugich, Tally M. Largent-Milnes, Josh J Havelin
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 28(1)
Most commonly originating from breast malignancies, metastatic bone cancer causes bone destruction and severe pain. Although novel chemotherapeutic agents have increased life expectancy, patients are experiencing higher incidences of fracture, pain,
Autor:
Mark A. Nelson, Courtney Wright, Alysia N. Lozano-Ondoua, Todd W. Vanderah, Tamara King, Patrick W. Mantyh, Anna Vardanyan, Juan Miguel Jimenez-Andrade, Tally M. Largent-Milnes
Publikováno v:
Life sciences. 86(17-18)
Aims Cannabinoid CB 2 agonists have been shown to alleviate behavioral signs of inflammatory and neuropathic pain in animal models. AM1241, a CB 2 agonist, does not demonstrate central nervous system side effects seen with CB 1 agonists such as hypot